[Diagnostics and treatment of ocular toxoplasmosis : Results of a survey].

Taghavi-Eraghi, A; Garweg, J G; Pleyer, U (2023). [Diagnostics and treatment of ocular toxoplasmosis : Results of a survey]. Die Ophthalmologie, 120(2), pp. 191-199. Springer 10.1007/s00347-022-01691-7

[img]
Preview
Text
s00347-022-01691-7.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (435kB) | Preview

BACKGROUND

Ocular toxoplasmosis (OT) is the most common infectious cause of posterior uveitis. This survey aimed to evaluate the current diagnostic and therapeutic approach to OT in Germany.

MATERIAL AND METHODS

A detailed questionnaire with specific patient examples was sent in July 2021 to the members of the Uveitis Section of the German Ophthalmological Society (DOG) and the Retinological Society (RG).

RESULTS

The questionnaire was answered by 53 (29 RG and 24 DOG) ophthalmologists. Of the respondents 16 (30%) work in private practice, 18 (34%) in a clinical facility and 19 (36%) in university hospital, 9 (17%) colleagues see < 50, 28 (53%) 50-200 and 16 (30%) more than 200 uveitis patients per year. The clinical results are still the gold standard (87%) for the diagnosis of OT and in cases of first manifestation 60% are supported by serological antibody investigations, while 10 out of 53 (19%) ophthalmologists rely on the clinical presentation only. An IgM test is requested by 25 (47%) respondents, 6 expected an increase in IgG titer (11%) and 1 the detection of specific IgA antibodies (2%). The majority (n = 28, 53%) of ophthalmologists would aim at confirming the diagnosis by an anterior chamber puncture, from which 20 (38%) prefer PCR, 3 (6%) determination of Goldmann-Witmer coefficients (GW) and 5 (9%) a combination of both methods. Clindamycin was most frequently used for treatment (n = 21, 40%), followed by pyrimethamine/sulfadiazine (n = 17, 32%) and trimethoprime + sulfamethoxazole (TMP/SMX) (n = 10, 19%); the latter was also used (n = 40, 75%) for secondary prophylaxis.

CONCLUSION

The results show that apart from the clinical results as the gold standard for the diagnosis, there is no uniform approach to diagnosis and treatment of OT. The high request rate for serum IgM antibodies indicates a widespread uncertainty about the importance of serological findings. This should be viewed critically, given the continued high seroprevalence in Germany.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Garweg, Justus

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2731-7218

Publisher:

Springer

Language:

German

Submitter:

Pubmed Import

Date Deposited:

05 Aug 2022 14:16

Last Modified:

04 Feb 2023 00:12

Publisher DOI:

10.1007/s00347-022-01691-7

PubMed ID:

35925359

Uncontrolled Keywords:

Antibody investigations Combination treatment Secondary prophylaxis Serology Uveitis

BORIS DOI:

10.48350/171758

URI:

https://boris.unibe.ch/id/eprint/171758

Actions (login required)

Edit item Edit item
Provide Feedback